{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpsychiatry-tomorrow.simplecast.com%2Fepisodes%2Fanita-clayton-Mw14MNeB","width":444,"version":"1.0","type":"rich","title":"The Psychiatrist Who Fought the FDA Over How Women's Desire Gets Measured | Anita Clayton, MD","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/78201557-8217-4bdf-b5e9-8b7e5f52b506/2852e86a-a66a-4ffb-93c4-c5e141a186be/podcast_episode_art_anita_clayton.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/557375a4-a8be-4766-9c5c-b11f0bad558f\" height=\"200\" width=\"100%\" title=\"The Psychiatrist Who Fought the FDA Over How Women&apos;s Desire Gets Measured | Anita Clayton, MD\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"2-sentence description:\n\nDr. Anita Clayton — UVA's chair of psychiatry and the researcher who built the field's standard scale for measuring antidepressant sexual dysfunction — joins Dr. Will Sauvé and Dr. Brittany Albright to trace a career spent proving what drug labels wouldn't say. From a fluoxetine label that said 1.9% when she was seeing 20% in clinic, to fighting the FDA over how women's desire gets measured, to the postpartum and depression treatments she's running trials on right now."}